ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,062.00
-0.10%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.35345
-0.60%
Bitcoin
66,786.85
-0.23%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. TRACON Pharmaceuticals Inc (TCON)

  7. TRACON Pharmaceuticals Inc (TCON) News

TCON

TRACON Pharmaceuticals (TCON)

TRACON Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TCON
DateTimeSourceHeadlineSymbolCompany
05/14/20244:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCONTRACON Pharmaceuticals Inc
05/14/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
05/13/20244:00PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCONTRACON Pharmaceuticals Inc
05/13/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
03/07/20244:03PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TCONTRACON Pharmaceuticals Inc
03/05/20244:00PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TCONTRACON Pharmaceuticals Inc
02/28/20243:02PMGlobeNewswire Inc.TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024NASDAQ:TCONTRACON Pharmaceuticals Inc
02/14/20243:31PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCONTRACON Pharmaceuticals Inc
02/09/20243:05PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TCONTRACON Pharmaceuticals Inc
12/19/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
12/08/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
11/20/20237:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
11/09/20234:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCONTRACON Pharmaceuticals Inc
10/06/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
09/18/20237:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
09/07/20233:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
08/14/20234:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCONTRACON Pharmaceuticals Inc
08/14/20233:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
08/07/20234:02PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TCONTRACON Pharmaceuticals Inc
07/25/20234:19PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TCONTRACON Pharmaceuticals Inc
07/11/20237:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
06/20/20237:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
06/15/20237:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
06/09/20234:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
06/02/20234:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
06/02/20233:47PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TCONTRACON Pharmaceuticals Inc
06/01/20235:06AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TCONTRACON Pharmaceuticals Inc
05/31/20233:22PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:TCONTRACON Pharmaceuticals Inc
05/19/20234:02PMEdgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:TCONTRACON Pharmaceuticals Inc
05/10/20233:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TCON

Your Recent History

NYSE
LLY.51
Lilly (Eli) &
NYSE
AVA-AL
DGFX
XORUSDT
Sora Token
ASX
SIG
Sigma Healthcare
HITB
USNOTAETH
USNOTA
POLO
ALICEUSDT
ALICE [My Neighbor Alice]
COIN
PRXGBP
COIN
CADXXGBP
NASDAQ
MSSN
Mission Resources
AMEX
STCE
Schwab Crypto Thematic ETF
BIT
Z16430
Credit Suisse
ASX
PIENA
EU
FRSOG
Euronext France Social GR
NASDAQ
DICE
DICE Therapeutics
LSE
DP3E
AMEX
HMOP
Hartford Municipal Oppor...
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved